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Summary.-Host responsiveness to a progressively growing methylcholanthrene
(MC) induced tumour (MC6/2) was studied at varying intervals following subcuta-
neous (s.c.) tumour implantation bymonitoring the in vitroincorporation oftritiated
thymidine (3H-TdR) into lymph node cells (LNC) undergoing stimulation in vivo and
concurrently determining the total numbers of the lymphoid cells present in these
organs at each of the time intervals. It was found that an initial period of rapidly
increasing stimulation of DNA synthesis in lymph nodes was soon followed by the
onset of a stage of decrease of this activity. Within limits, the larger the tumour
inoculum the stronger the initial response. The suppression of stimulation of DNA
synthesis that ensued appeared to be directly related to the tumour mass and to the
dose of tumour cells implanted. The total numbers of the cells accumulating in
nodes also increased initially but remained elevated during the subsequent period
of tumour growth. Continued presence of the tumour was essential for the increased
DNA synthesis in lymph nodes since tumour removal leads to a rapid decrease to
levels found in tumour-free animals. These findings demonstrate that the failure to
eradicate an antigenic tumour by its host may not be solely due to " desensitizing"
and " blocking " factors but that other important mechanisms are also involved.
We suggest that the inability to reject the tumour in this situation is dependent in
considerable measure on the development of a state of hyporeactivity in the host due
to the partial inhibition of the DNA synthetic response, possibly in T cells of the
tumour host, due to " suppressor factor(s) " interacting with the immunocompetent
cells.
EVIDENCE available at present indi-
cates that " blocking mechanisms "
(Hellstrom and Hellstrom, 1969;
Hellstrom et al., 1969; Sjogren et al., 1971;
Baldwin, Price and Robins, 1972) play a
considerable role in the depression of
immunity developing in the tumour bear-
ing individual at the effector or at the
target cell level. On the other hand,
inappropriate or inadequate stimulation
of the tumour host is implicated in the
works of Evans et al. (1962) Haddow and
Alexander (1964) and Haddow (1965). A
numberofinvestigators havereportedthat
the large pyroninophilic cell response in
the paracortex ofdraining lymph nodes of
tumour implanted animals is rapidly
exhausted duringtumourgrowth (Rosenau
and Moon, 1966; Alexander et al., 1969;
Edwards et alt., 1971; Chandradasa, 1973).
In certain tumour systems enhancing or
blocking activity could not be detected in
the serum either in vivo (Vaage, 1972) or
in vitro (Deckers et al., 1973). Evidence
was presented in a previous communica-
tion (Chandradasa, 1973) thatconcomitant
immunity developed in the host is sub-
jected to a rapid and specific suppression
during the progressive growth oftumours.
In transfer studies it was also observed
that the specifically cytotoxic lymphoid
cells developing in the lymphoid organs of
tumour implanted mice decreased either
in proportion or in effectiveness duringK. D. CHANDRADASA AND J. BRADLEY
tumour bearing. These findings have
been supported by the observations of a
number of other workers (Vaage, 1973;
Deckers et al., 1973; Whitney, Levy and
Smith, 1974). Both Deckers et al. (1973)
as well as Whitney et al. (1974) have
provided evidence from in vitro studies
that progressive growth oftumoursbeyond
a certain early stage results in a loss or
decline of the cell mediated immunity of
the tumour host. These experiments
were conducted under conditions where
"blocking factors " were considered un-
likely to intervene and hence add support
for an afferent or a central block of the
immune response.
We present evidence in this paper for
the development of a state of hypo-
reactivity to the tumour within the lymph
node cell population of the host during
tumour bearing.
MATERIALS AND METHODS
Mice.-Inbred mice of the Balb/c strain,
as previously described (Chandradasa, 1973)
were used in all experiments performed in
this work.
Tumour.-Tumour MC6/2 used in the
present studies is a tumour line derived from
the MC6 described previously (Chandradasa,
1973) by the conversion ofthat tumour to the
ascitic form after the 15th transplant
generation. Thereafter it was propagated
intraperitoneally under aseptic conditions.
The MC6/2, like its parental form, induced a
high level of concomitant immunity during
s.c. growth enabling the rejection of a
challenge tumour dose of 2 x 106 cells by
16/17 mice, while the minimum overthreshold
dose of2 x 104 cells gave rise to progressively
growing tumours in 100% of the normal ani-
mals. The tumourutilized inthese studies was
taken only from the 10th-36th transplant
generations passaged in the ascitic form.
In vivo techniques of tumour transplanta-
tion and tumour challenge.-The tumour cells
obtained in the ascitic form were washed
twice in Eagle's Minimum Essential Medium
(MEM) containing 100 jig streptomycin and
100 i.u. benzylpenicillin per ml, resuspended
in the same medium and the required number
ofviable cells were inoculated subcutaneously
onto the middle area of the flank, under
aseptic conditions.
The cell inocula used in the following
experiments, viz. 2 x 104, 105, 5 x 105
and 107 all gave rise to progressively growing
tumours. The survival of mice bearing
such tumours was restricted to a period of
between 30 and 55 days, the life expectancy
being longer with a smaller size of tumour
inoculum.
Surgical excision of tumours -Tumour
excision under aseptic conditions was per-
formed under ether anaesthesia. The edges
of the skin were sutured using surgical silk
and the wound covered with collodion.
Wounds healed completely within 2 weeks.
Determination of the weights of tumours.-
Tumours were carefully freed from tissues of
host origin. They were blotted with several
layersof"Kleenex" tissuepaper3timesbefore
being weighed to the nearest mg.
Preparation oflymph node cell suspensions.
-Ipsilateral and contralateral axillary and
inguinal lymph nodes were harvested under
aseptic conditions into RPMI 1640 medium
and were washed twice in the same medium.
They were gently teased apart using finely
pointed forceps in RPMI 1640 and the cells
were passed through a 160 mesh stainless
steel gauze. Cell suspensions were washed
once at 250 g for 7 min and the sedimented
cells were resuspended in 2 ml RPMI 1640
containing 10% heat inactivated foetal calf
serum (FCS) plus 100 ,ug streptomycin and
100 i.u. benzylpenicillin per ml (RPMI/FCS).
The cell viability and total viable cells/ml
were determined as for tumour cells. The
LNC suspensions thus prepared were used for
the incorporation of tritiated thymidine.
To determine the total number of mono-
nuclear cells present in the lymph nodes,
whole nodes were first teased apart in
phosphate buffered saline (PBS) using finely
pointed forceps. The liberated cells were
first harvested and the remaining tissue
pieces were gently ground in Griffiths tubes
(Baird and Tatlock Ltd, Manchester, Eng-
land) using 5 ml of PBS until all the cells had
been liberated. The cells were washed in 5 ml
PBS, spinning at 250 g for 10 min. The cell
sediment was resuspended in a suitable
volume of PBS and the cell counts were
performed in leucocyte diluting fluid in a
Neubauer haemacytometer. The total cells
obtained from lymph nodes or similarly
treated spleens were then calculated.
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Incorporation of 3H-TdR into lyrnphoid
cells.-The lymphoid cell suspensions were
diluted in RPMI/FCS medium to provide 106
cells/ml and put into sterilized plastic tubes
(PT 1260, Luckham Ltd, Labro Works,
Victoria Gardens, Burgess Hill, Sussex) in
0 5 ml amounts (5 x 105 cells). Tubes were
prepared in quadruplicate for each set ofnode
cells obtained from individual mice. Cell
preparations with viability below 80% were
discarded. 3 ,uCi of 3H-TdR (5 Ci/mmol)
(Radiochemical Centre, Amersham) in 0-1 ml
of RPMI/FCS was added to each tube and
these were incubated in a 50 CO2 950 air
atmosphere for 2 h at 37°C. The time of
removal of the lymphoid organs to the start
of incubation was 21-3 h (see Fig. 1). At
the end of the incubation, 1 ml of cold (4°C)
PBS was added to each tube and the tubes
were washed twice at 500 g for 7 min using
1 ml of the same medium. After the second
wash 1 ml of 10% trichloracetic acid (TCA)
was added and the tubes were left overnight
at 4°C. They wvere then washed 3 times in
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1 ml of cold 10% TCA and finally with 1 ml
of Analar methanol. The tubes were dried
and the precipitate was dissolved in 0-2 ml of
Hyamin (Packard Instrument International
SA, Talstrasse 39, 8001 Zurich, Switzerland)
overnight. The contents were transferred to
counting vials in 0-8 ml of Analar methanol
and counted for 50 min using a toluene-triton
scintillation cocktail in a Beckman LS 200 B
scintillation counter. Results were expressed
as the mean ct/min obtained from 4 replicate
tubes minus the background ct/min.
Technique for assaying the in vivo state of
stimulation of tumour bearer LNC.-The
experimental procedure used for the assess-
ment of tumour bearer LNC stimulation was
previously established by the authors (Fig. 1).
It was observed that the in vitro incorpora-
tion of 3H-TdR into the in vivo stimulated
LNC declined rapidly after the preparation
ofthe cell suspensions and start ofincubation.
The uptake of 3H-TdR was rapid during the
first 3-4 h of incubation but the rate of
incorporation of the label decreased steadily
during the same period. In normal LNC the
slope of incorporation was similar but
occurred at a much lower level compared with
the sensitized LNC (see Fig. lA, B). At the
end of a 2-h incubation the incorporation of
the label nearly doubled that of a one-h
incubation, the 00 increases during the
second h of incubation being 53% for sensi-
tized and 410% for normal LNC. The period
of incubation selected for the present experi-
ments was found to be both satisfactory and
convenient. This technique may have valu-
able potential for the assessment ofthe in vivo
reactivity to tumour and other tissues and in
monitoring the immune response during
tumour bearing in the human disease.
RESULTS
Stimulation of DNA synthesis in LNC of
tumour bearing mice
o 1 2 3 4 5) 6 Ln a series ot experiments tumour
h MC6/2 was implanted s.c. into 4 groups,
each of 3 mice which received 2 x 104 1. The rate of incorporation of 3H-TdR o vitro into LNC stimulated in vivo. 105, 5 X 105, or 107 tumour cells. Normal
; x 105 LNC prepared from tumour stimu- untreated mice of the same age and sex ated (A) or normal (B) mice were in- were used as controls. At 10 and 20 days
-ubated with 3H-TdR at 37°C and their
)NA synthesis was arrested at hourly and in one group at 30 days, the ipsilateral
ntervals thereafter. The incorporation of and contralateral LNC stimulation was
'he label was studied in quadruplicate tubes examined individually. In each mouse nd each point in Fig. represents a meani 'alue. the tumour weight and the total number of
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cells present in the spleen and in the
ipsilateral and contralateral nodes were
carefully determined.
The results of these experiments are
shown in Table I and in Fig. 2A, B and
Fig. 3. It is obvious that the ct/min/
5 x 105 cells increase, but this increment
does not reflect the total activity of the
lymph nodes because the total cells in
nodes also increase in number. Therefore
the ct/min/LNC have been multiplied by
the total cell content to give the total
ct/min/set of nodes.
The incorporation of 3H-TdR has been
expressed as: (1) the ct/min obtained by
incubating 5 x 105 LNC (proportional
l0
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incorporation): (2) as a total ct/min
obtained by calculating the ct/min for the
total number of cells in the ipsi or contra-
lateral nodes, providing a measure of the
total stimulation: (3) as an index of
relative stimulation obtained by dividing
the ct/min/5 x 105 LNC in the test nodes
by the equivalent of a normal control
group; and (4) as an index of total
stimulation which is the value obtained by
dividing the total ct/min in test nodes by
that of the normal controls.
The results show that in the different
groups of mice implanted with tumours,
the incorporation of 3H-TdR into 5 x 105
ipsilateral LNC during the first 10 days
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FIG. 2A FIG. 2B
FIG. 2A, B.-Stimulation of DNA synthesis in lymph nodes of Balb/c mice bearing MC6/2 tumour at
a s.c. site. 2 x 104, 105, 5 x 105 or 107 tumour cells were implanted s.c. at Day 0 and at Days 10
and 20 incorporation of 3H-TdR by 5 x 105 ipsilateral or contralateral LNC were studied in vitro
in replicates of 4 tubes. Incorporation of the label into (5 x 105) LNC from normal mice was
studied simultaneously as controls. Fig. 2A indicates the uptake of 3H-TdR by 5 x 105 LNC at
the two-time intervals. Fig. 2B shows the index of relative stimulation which is the mean incor-
poration in 5 x 105 test LNC/corresponding value in normal LNC. Each column represents a
mean value obtained from a group of 3 mice and the lines on top of columns show the s.e. mean.
DNA synthesis (2A) and the index ofrelative stimulation (2B) in Fig. are indicated as follows: clear
columns, ipsilateral LNC: dotted columns, contralateral LNC. Hatched columns show the DNA
synthesis in normal LNC. The number oftumour cells implanted at Day 0, are indicated by simple
letters, a = 107, b = 5 x 105, C = 105 and d = 2 x 104, and the changes in mean tumour weight
* 0) are shown. S.e., Standard error.
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Fie. 3. Changes in iindex of total stimulation
of the LNC in tumour bearing mice. The
index of total stimulation = total ct/min in
test lymph nodes/total ct/min in control
lymph nodes. (These values are shown in
Table I.) Clear columns, ipsilateral nodes:
(lotted columns, contralateral nodes. Each
column represents a mean value obtaine(d
from a group of 3 mice. The s.e. meain is
indicated by the lines on top of the columns
and the changes in mean tumour weight
(0 * 0) and the number of tumoui
cells implanted at Day 0, a = 101, b = 5
X 105, C= 105 and d = 2 x 104 are also
shown. S.e. mean-- Standard error ofthe
mean.
increased 4-6 fold whereas the total ct/min
for the nodes increased 10-36 fold over the
corresponding values in normal control
mice. Stimulation of DNA synthesis in
LNC reached peak levels at 10 days, with
mice implanted with the larger doses of
5 x 105 or 107 tumour cells incorporating
markedly more 3H-TdR in LNC than the
groups implanted with the smaller doses-
this effect being more marked in the total
ct/min and in the indices of total ct/min
than in the ct/min/5 x 105 LNC values.
There is, however, a limit to further
stimulation by increasing the initial
tumour inoculum since the group im-
planted with 107 tumour cells incorporated
less 3H-TdR by the ipsilateral LNC com-
pared with the mice implanted with
a x 105 tumour cells. The difference in the
ct/min/5 x 105 LNC in the 2 groups at
10 days was found to be significant at the
500 level (0.02 < P < 0.05) and the differ-
ences in the corresponding indices of
relative stimulation (0.001 < P < 0.01)
or total stimulation (P < 0-001) were
highly significant.
The total numbers of the LNC present
in the ipsilateral and contralateral nodes
were found to be increased in the different
groups of mice at 10 days, in direct
relationship to the number of tumour cells
implanted up to 5 x 1_05. A similar
relationship was observed with the in-
crease of the cells present in spleens, up to
the largest tumour cell dose of 107
employed.
At 20 days, mice implanted with
x 105 or 107 tumour cells showed a
rapid decline of their DNA synthetic
response to tumour in the LNC. The
decrease in the incorporation of 3H-TdR
into 5 x 105 LNC or into the total cell
population of the ipsilateral nodes of the
first category of mice bore a high level
of significance (P < 0.001). The fact
that the normal control LNC at 20
days also had decreased DNA synthesis
could leave the possibility that in test
LNC the fall of DNA synthesis may
have been exaggerated, but the test
LNC activity, when related to the per-
formance in normal LNC (see relative
index of stimulation, Table 1) still showed
significance (0.01 < P < 0.02). Their
contralateral LNC also showed a signi-
ficant decrease of 3H-TdR incorporation
both proportionally (P < 0.01) as well as
totally (0.01 < P < 0.02). Similar
changes were observed in the ipsilateral
LNC of mice implanted with 107 tumour
cells with significant decreases in propor-
tional (0.001 < P < 0.002) as well as in
total incorporation of 3H-TdR (0.01 < P
< 0.02), although no significant change
was noted in the contralateral node cells.
These observations were made during, a
-4
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period when the tumour weight increased
more than three-fold in the group im-
planted with 5 x 105 tumour cells or
nearly twice as in the group implanted
with 107 cells.
Mice which received smaller doses of
2 x 104 or 105 tumour cells provided a
different picture. In the first category of
mice no significant change in either the
ct/min/5 x 105 cells or in the indices of
stimulation of LNC was noted between 10
and 20 days, while in terms of total
stimulation the 20-day values of both ipsi-
and contralateral LNC were apparently
elevated, although this failed to reach
significance at the 50% level (0.05 < P
< 0.1). There was a significant (P
< 0.001) increase in the accumulated
LNC in both ipsi- and contralateral
lymph nodes at 20 days, which no doubt
contributed to the increased total radio-
activity. In mice implanted with 105
tumour cells, no significant increase of
either the proportional stimulation or the
indices ofrelative or total stimulation was
noted but the total stimulation in both
ipsi- and contralateral nodes was raised
above the values at 10 days. This was
found to be significant (0.01 < P < 0.05).
The tumours in these 2 groups of mice
remained below 1 g during this period of
investigation, but had more than doubled
in weight between 10 and 20 days. It was
also noted that their spleens had accumu-
lated numbers of cells comparable with
that present in other groups at the same
stage.
In the group of mice tested at 30 days
in which the tumours were initiated with
an inoculum of 2 x 104 tumour cells, the
ct/min/5 x 105 LNC or the relative index
of stimulation in both ipsi- and contra-
lateral nodes did not show a significant
decrease below the corresponding levels at
20 days. However, the decreases in the
indices of total stimulation were signi-
ficant in both the ipsilateral (0.02 < P
< 0.05) as well as in the contralateral
nodes (0.002 < P < 0.01) as was the total
ct/min in the contralateral nodes (0.002 <
P < 0.01).
Effect of tumour excision on the uptake of
3H-TdR by LNC1
Tumour MC6/2 was implanted s.c. into
the right flank of 14 mice. A third group
of 7 mice was set aside as normal controls.
Ten days later the tumours were com-
pletely excised surgically from Group I
(6 mice) while Group II (8 mice) and
Group III (7 mice) received sham opera-
tions. Seven days following these treat-
ments the axillary and inguinal lymph
nodes were carefully removed from the
tumour excised or tumour bearing flanks
of the Group I and Group II mice and
from the sham operated flank ofthe Group
III mice. The LNC preparations from the
3 groups of mice were then tested for their
ability to incorporate 3H-TdR in vitro.
TABLE IT.-Effect of Excision of Tumour on the Tumour Stimulated DNA
Synthesis in LNC*
Treatmernt,
Group II
Tumour MC 6/2 s.c.
Group I for 10 days Group III
Tuimouir MC 6/2 s.c. sham excisioni Normal controls
for 10 days of tumour sham operation
excision of tumour + 7 days following + 7 days following
7 days free of tumour sham excision sham operation
No. of mice in group 6 8 7
ct/min/5 x 105LNC -4- s.e. meant 673-27 X 232-9 1917-37 ± 234-8 866-27 + 43-5
I06MC 6/2 cells were implanted subcutaneously at Day 0 into groups I and II and the tumours were
excised from group I on Day 10, while the groups II and III were sham operated at the same time. On
Day 17 the ipsilateral LNC of groups I and II and the corresponding LNC from the sham operated flank of
grotup III wvere tested for their stimulated DNA synthesis by incubating 5 x 105 cells with 3H-TdR.
* LNC = LLymph node cells. t s.e. mean = Standard error of the mean.
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The results of this experiment are
shown in Table II. The mice in Group II
bearing tumours incorporated 3H-TdR
significantly more than those in Group I
(P < 0.001) or those in Group III (P
< 0-001) while no significant difference
was noted between 3H-TdR incorporation
in Groups I and III.
DISCUSSION
These results (see Table I, Fig. 2A, B
and Fig. 3) indicate the existence of 2
different phases of stimulation of DNA
synthesis within the LNC of the tumour
bearing mice studied here. During the
first phase, which lasted about 10 days,
the stimulation of DNA synthesis bore,
within limits, a direct relation to the
tumour mass present. Thus, it can be
seenfrom Table I and Fig. 2A, B that peak
levels of incorporation of 3H-TdR into
5 x 105 LNC resulted in all groups of
mice at 10 days. During the second
phase, a marked retardation in the rate
of stimulation of LNC was observed. In
the groups that were implanted with the
larger doses of 5 x 105 or 107 tumour cells
this led to a significant decrease in the
stimulation ofLNC at 20 days, whereas in
those that were given the smaller doses of
2 x 104 or 105 cells it resulted in a
complete arrest of any further increase in
the rate of stimulation of DNA synthesis.
The increase in the total stimulation in
these mice at 20 days resulted from an
accumulation of LNC at this stage.
The specific nature of the response in
the MC6/2 implanted mice is indicated by
the findings on the effect of tumour
excision (Table II). These clearly show
the requirement ofthe continued presence
oftumour for the maintenance ofthe DNA
synthetic response in lymph nodes.
These observations may indicate the
presence ofa mechanism ofsuppression or
regulation of the immune response to the
tumours within the tumour host. The
initial period of about 10 days during
which the rate ofLNC stimulation steadily
increased mayalsorepresentaphaseduring
which the factors responsible for the
controlling influence begin to make their
appearance in the tumour host.
At present, much emphasis has been
focussed on the blocking effect of anti-
body, antigen or their complexes either at
the effector or at the target cell level.
Although this is now well established, it
has not always been adequate to explain
the experimental results observed(Deckers
etal., 1973; Vanky et al., 1973; Whitney et
al., 1974). The possibility that the tumour
host is not responding fully is often
masked by the demonstration ofits ability
to destroy a limited number of tumour
cells when reinoculated and also by the
detection in vitro of specifically cytotoxic
lymphoid cells present within its system.
In a previous report on the background
DNA synthesis in the spleen cells of
tumour bearing mice, Konda, Nakao and
Smith (1973) observed that this activity
initially increased but subsequently de-
creased with continuing growth of the
tumour. However, the absolute values
for the whole spleen remained elevated
during the course of tumour bearing.
This study was carried out using the gross
population ofthe spleen cells and therefore
cannot be taken as a measure of the
splenic lymphocyte DNAsynthesis. These
workers also reported a marked increase of
cells in the spleen responding to a variety
of non-tumour antigens and also that the
splenic haematopoietic cells capable of
colonyformation onadoptive transferwere
observed to be greatly increased during
tumour bearing. Whilst these observa-
tions are not contrary to those reported
here, our findings may gain strong support
from the observations of Vanky et at.
(1973) who showed that in mixed lympho-
cyte-target cell interaction tests, LNC
draining large tumours oflong duration in
human cancer, failed to respond to the
autochthonous tumour cells but retained
their ability to react to allogeneic lympho-
cytes or to phytohaemmaglutinin, indi-
cating the specificity of non-responsive-
ness.
We have shown that the host's LNC
response to the tumour becomes depressed
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soon after the early period of tumour
growth. This may find an interesting
correlation in the control of the delayed
hypersensitivity reaction in mice painted
with certain skin sensitizing agents (Asher-
son and Barnes, 1973; Zembala et al.,
1975). It has been shown that pretreat-
ment of mice with the picrylating agent
picryl sulphonic acid depresses or abolishes
the DNA synthetic response to the same
agent as well as to picryl chloride in the
lymph nodes, but not in the spleen.
Delayed hypersensitivity, but not the
antibody response, is markedly affected,
reflecting on the composition of these 2
types of lymphoid organs-the lymph
nodes consisting predominantly of " T "
cells while the spleen containing nearly
equal proportions ofboth " T " and " B "
cells (Raff, 1971). Although the DNA
synthetic response in the LNC of the
tumour bearing mice studied here may
not undergo such dramatic changes, it is
nevertheless possible that a similar basis
may underlie both these phenomena. It
would therefore beinterestingto seeifsuch
" suppressor factor(s) " could be demon-
strable in the tumour hosts and if so to
identify and studytheir immunobiochemi-
cal nature.
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